Histone Deacetylase Inhibitors Reduce Cysts by Activating Autophagy in Polycystic Kidney Disease
Author(s) -
Liping Sun,
Chaofeng Hu,
Xinzhou Zhang
Publication year - 2019
Publication title -
kidney diseases
Language(s) - English
Resource type - Journals
eISSN - 2296-9381
pISSN - 2296-9357
DOI - 10.1159/000499368
Subject(s) - autophagy , autosomal dominant polycystic kidney disease , pkd1 , ampk , trichostatin a , polycystic kidney disease , cancer research , histone deacetylase , chemistry , kidney , medicine , microbiology and biotechnology , endocrinology , biology , apoptosis , kinase , protein kinase a , histone , biochemistry , gene
Histone deacetylase inhibitors (HDACi) have therapeutic effects on various models of renal diseases including autosomal dominant polycystic kidney disease (ADPKD), but the molecular mechanism is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom